Skip to main content
Fig. 4 | BMC Medical Imaging

Fig. 4

From: Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France

Fig. 4

Scatter plot showing the uncertainty of the incremental cost-effectiveness ratio in Euros for each imaging modality. ICER = incremental cost-effectiveness ratio; NaF = 18F-sodium fluoride PET/CT; FCH = 18F-fluorocholine PET/CT; DW-MRI = diffusion-weighted whole-body magnetic resonance imaging

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us